Understanding how the microbiome is involved in establishing, maintaining, and reversing obesity has been an active area of research 14,15,16 , and has included studies investigating links between the microbiome and obesity-related comorbidities such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 17,18
FDA reviewers have also cautioned that a peptides similarity to a naturally occurring substance does not eliminate potential risks
A review of structural and functional diversity of the primate temporal lobe
Gong Y, Liu M, Zhang Q, Li J, Cai H, Ran J, et al
The Gray Area: Conditions Requiring Extreme Caution Now we move from the hard stops to the yellow lights
Ercal says NACA is an improvement over another experimental treatment, the antioxidant N-acetylcysteine (NAC), because it passes more easily across cell membranes, allowing the medication to be used in lower doses